In a small trial, immune cells that fight the Epstein-Barr virus have stopped the progression of multiple sclerosis, an autoimmune condition that can lead to symptoms, such as difficulty walking, that worsen over time
11 April 2022
Transplants of immune cells that target the Epstein-Barr virus have shown promise for treating multiple sclerosis in an early stage trial. Brain scans suggest the progression of the condition was reversed in some participants, but this needs to be confirmed by larger trials.
Multiple sclerosis (MS) is caused by someone’s own immune system attacking the myelin coating that helps nerve cells conduct signals, causing a range of symptoms from fatigue to difficulty walking. In most cases, …